1. Home
  2. MPB vs IVA Comparison

MPB vs IVA Comparison

Compare MPB & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPB
  • IVA
  • Stock Information
  • Founded
  • MPB 1868
  • IVA 2011
  • Country
  • MPB United States
  • IVA France
  • Employees
  • MPB N/A
  • IVA N/A
  • Industry
  • MPB Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MPB Finance
  • IVA Health Care
  • Exchange
  • MPB Nasdaq
  • IVA Nasdaq
  • Market Cap
  • MPB 655.5M
  • IVA 769.0M
  • IPO Year
  • MPB N/A
  • IVA 2020
  • Fundamental
  • Price
  • MPB $29.42
  • IVA $4.10
  • Analyst Decision
  • MPB Buy
  • IVA Strong Buy
  • Analyst Count
  • MPB 2
  • IVA 7
  • Target Price
  • MPB $36.00
  • IVA $16.57
  • AVG Volume (30 Days)
  • MPB 112.6K
  • IVA 366.1K
  • Earning Date
  • MPB 10-22-2025
  • IVA 09-29-2025
  • Dividend Yield
  • MPB 3.07%
  • IVA N/A
  • EPS Growth
  • MPB N/A
  • IVA N/A
  • EPS
  • MPB 2.41
  • IVA N/A
  • Revenue
  • MPB $208,798,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • MPB $26.19
  • IVA N/A
  • Revenue Next Year
  • MPB $28.25
  • IVA N/A
  • P/E Ratio
  • MPB $11.90
  • IVA N/A
  • Revenue Growth
  • MPB 20.40
  • IVA N/A
  • 52 Week Low
  • MPB $22.50
  • IVA $2.11
  • 52 Week High
  • MPB $33.87
  • IVA $7.98
  • Technical
  • Relative Strength Index (RSI)
  • MPB 55.04
  • IVA 39.92
  • Support Level
  • MPB $28.25
  • IVA $3.86
  • Resistance Level
  • MPB $29.95
  • IVA $4.42
  • Average True Range (ATR)
  • MPB 0.62
  • IVA 0.68
  • MACD
  • MPB 0.12
  • IVA -0.17
  • Stochastic Oscillator
  • MPB 77.91
  • IVA 7.50

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: